Analysts expect Novartis (NVS) to complete a bullish reversal with potential upside target near $176
Novartis is approaching a potential breakout point that could signal a bullish reversal, with analysts suggesting a target price of around $176 if the stock maintains its current momentum. This development is significant as it indicates a sustained uptrend following a lengthy consolidation period.